Belelli D, Pau D, Cabras G, Peters J A, Lambert J J
Department of Pharmacology and Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Scotland.
Br J Pharmacol. 1999 Jun;127(3):601-4. doi: 10.1038/sj.bjp.0702611.
Many structurally diverse general anaesthetics enhance inhibitory neurotransmission in the central nervous system by interacting with the GABAA receptor. By contrast, GABA receptors composed of the rho 1 subunit are anaesthetic-insensitive. Here, we demonstrate that both delta-hexachlorocyclohexane (delta-HCH; 1-100 microM), a positive allosteric modulator of the GABAA receptor, and the anaesthetic pentobarbitone (10-600 microM) have no effect on GABA-evoked currents mediated by wild-type rho 1 recombinant receptors (expressed in Xenopus laevis oocytes). By contrast, these agents produce up to a 10 fold enhancement of GABA responses transduced by a rho 1 receptor in which a transmembrane located isoleucine residue is replaced by serine. However, not all general anaesthetics were similarly influenced by this mutation, because propofol and 5 beta-pregnan-3 alpha-ol-20-one (5 beta 3 alpha) remained ineffective. These data are discussed in relation to the specificity of general anaesthetic action.
许多结构各异的全身麻醉药通过与GABAA受体相互作用来增强中枢神经系统中的抑制性神经传递。相比之下,由rho 1亚基组成的GABA受体对麻醉药不敏感。在此,我们证明,GABAA受体的正变构调节剂δ-六氯环己烷(δ-HCH;1-100微摩尔)和麻醉药戊巴比妥(10-600微摩尔)对野生型rho 1重组受体(在非洲爪蟾卵母细胞中表达)介导的GABA诱发电流均无影响。相比之下,这些药剂可使由rho 1受体转导的GABA反应增强多达10倍,其中一个位于跨膜区的异亮氨酸残基被丝氨酸取代。然而,并非所有全身麻醉药都受到这种突变的类似影响,因为丙泊酚和5β-孕烷-3α-醇-20-酮(5β3α)仍然无效。这些数据结合全身麻醉作用的特异性进行了讨论。